Overview
The mission of the Birth Defects Initiative is to capitalize on genomic and other biomedical discoveries to further understanding of the mechanisms responsible for structural birth defects, which affect about 3% of all live births in the United States each year.
The goal of the initiative is the development of new, innovative, and valuable strategies for the molecular diagnosis, treatment, and prevention of human structural birth defects. It is led by the Developmental Biology and Congenital Anomalies Branch (DBCAB), formerly known as the Developmental Biology and Structural Variation Branch.
Through the initiative, DBCAB supports basic scientists and clinicians whose research projects span basic, translational, and clinical approaches to understanding the developmental biology and genetics of structural birth defects.
More Information
- NICHD Contact: Reiko Toyama
BACK TO TOP